RHIM LSE Week ended 07 Aug 2026

Weekly Investor Report

RHI Magnesita N.V. · Industrials · Metal Fabrication

Open interactive chart View report data
Latest close 3,115 GBP
10.3% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 10.9% above the Trend Line and sits at 81.4% of its 52-week range. The latest completed week returned 10.3%, after a 12.7% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers. The latest news-sentiment score is 51/100.

Setup score 71 out of 100
Latest Close 3,115 GBP 7 Aug 2026
1W Return 10.3% latest completed week
4W Return 12.7% short-term follow-through
12W Return 17.6% quarterly tape
Trend Breadth 50.0% 26 of 52 weeks active
Volume Ratio 1.7x vs 13-week average
What is working
  • The trend backdrop is active with a 17-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • No major top-level risk cluster is currently dominant.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 10.3% Latest completed week; four-week move 12.7%. Indicator stack 72/64 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 51/100 14 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 10.9% above the Trend Line and sits at 81.4% of its 52-week range. The latest completed week returned 10.3%, after a 12.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7512-week average 0.58

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.75Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 12.7% over four weeks, 17.6% over 12 weeks, and 38.5% over one year. The current trend has remained active for 17 consecutive weeks.

Performance by holding period

1W10.3%
4W12.7%
12W17.6%
26W12.5%
52W38.5%
Active trend streak17 weeks
Active weeks in one year26
Trend breadth50.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.54Latest activity-pressure read.
Pressure change56.0%Four-week change in activity pressure.
Leadership11.54Latest relative-leadership reading.
RS change587.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Dec 2025 Field coverage 91% Model confidence 72%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength82/100Blend of value, momentum, and quality. Underlying universe rank 19; rank 1 is best.
Value92/100Relative valuation strength. Underlying universe rank 9; rank 1 is best.
Quality10/100Profitability and accounting quality. Underlying universe rank 91; rank 1 is best.
Momentum92/100Medium-term price momentum. Underlying universe rank 9; rank 1 is best.
Growth3/100Revenue and earnings growth. Underlying universe rank 98; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework46/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
17.1x
Price divided by trailing earnings.
Price / sales
0.4x
Market value relative to trailing revenue.
EV / EBITDA
7.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
8.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
22.9%
Gross profit retained from each unit of revenue.
Operating margin
7.4%
Operating profit retained from revenue.
Free-cash-flow margin
8.0%
Free cash flow generated from revenue.
Return on invested capital
7.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-3.5%
Latest one-year revenue growth.
EPS growth
-39.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-6.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
4.9%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
4.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 14 relevant articles.

2 positive · 11 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-8.1%Distance below the 52-week high.
13-week volatility5.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2610 weeks finished lower.
Best week+10.3%Week of 7 Aug.
Worst week-26.9%Week of 13 Mar.
Latest week+10.3%Week of 7 Aug.

Shape of recent returns

Strong gains9
Modest gains6
Flat weeks1
Modest losses5
Sharp losses5
Recent vol5.1%13-week weekly-return volatility.
Base vol6.3%52-week weekly-return volatility.
Up/down split28/20Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryGB Metal Fabrication
4-week rank1 / 1
Group average12.7%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD100.0%positive activity pressure
RS100.0%positive relative leadership

Four-week leaders

RHIM · LSE12.7%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape68/100

Trend, activity pressure, participation, and risk combine to a 68/100 tape read.

 Indicator analysis80/100

Latest 12-week confirmation: trend 12/12, activity pressure 8/12, relative leadership 12/12.

Activity pressure 0.75; No reversal markers Factors67/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 79; Small Cap Core rank 18 SVQF46/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 140.5 of 260 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment51/100

Weighted news tone is neutral across 14 relevant articles.

RHI Magnesita NV Revenue Breakdown – LSE:RHIM Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20263,115 GBP10.3%2,810 GBP3,001 GBP0.5411.54104.3KOn
31 Jul 20262,825 GBP-3.6%2,796 GBP3,000 GBP0.281.75135.9KOn
24 Jul 20262,930 GBP-0.8%2,793 GBP3,001 GBP0.296.3446.0KOn
17 Jul 20262,955 GBP6.9%2,786 GBP3,001 GBP0.328.1247.3KOn
10 Jul 20262,765 GBP-4.3%2,774 GBP3,000 GBP0.351.6843.5KOn
3 Jul 20262,890 GBP1.2%2,767 GBP3,000 GBP0.333.8615.4KOn
26 Jun 20262,855 GBP-2.2%2,755 GBP2,998 GBP0.163.7614.8KOn
19 Jun 20262,920 GBP0.0%2,740 GBP2,997 GBP0.147.3128.8KOn
12 Jun 20262,920 GBP2.8%2,722 GBP2,995 GBP-0.055.9413.5KOn
5 Jun 20262,840 GBP-4.9%2,691 GBP2,993 GBP-0.133.758.6KOn
29 May 20262,985 GBP3.5%2,667 GBP2,991 GBP-0.158.27140.1KOn
22 May 20262,884 GBP8.9%2,638 GBP2,985 GBP-0.353.7786.5KOn
15 May 20262,649 GBP-6.0%2,608 GBP2,980 GBP-0.43-2.7197.0KOn
8 May 20262,819 GBP3.5%2,587 GBP2,977 GBP-0.442.4775.6KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context